NasdaqGS:ERASBiotechs
Does Erasca’s Shift Into Russell Growth Indexes (ERAS) Quietly Redefine Its Biotech Investment Story?
In June 2026, Erasca, Inc. was removed from several Russell value and microcap benchmarks while being added to multiple Russell growth indexes, including the Russell 2000 and 3000 Growth series.
This simultaneous shift from value-oriented to growth-focused benchmarks highlights how index methodologies can quickly reclassify a company’s investment profile in institutional portfolios.
Next, we’ll examine how Erasca’s reclassification into growth-oriented Russell benchmarks shapes its...